By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxart, Inc. 

600 Townsend Street
Suite 120E
San Francisco  California  94103  U.S.A.
Phone: 415-437-0132 Fax:




Company News
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines 3/25/2016 7:36:42 AM
Vaxart, Inc. Begins Preclinical Testing Of An Oral Zika Virus Vaccine 3/3/2016 10:50:32 AM
Vaxart, Inc. Appoints Samir Singh As Senior Vice President, Corporate Development And Strategy 2/9/2016 9:55:37 AM
Vaxart, Inc. To Present At Leerink Partners Global Healthcare Conference 2/4/2016 10:14:35 AM
Vaxart, Inc. Announces Enrollment Of First Patient In Influenza B Phase I Trial 12/17/2015 8:28:27 AM
Vaxart, Inc. Awarded $13.98 Million HHS-BARDA Contract To Support Advanced Development Of Influenza Tablet Vaccine 10/28/2015 11:17:57 AM
Vaxart, Inc. To Present Key Data Related To Its Oral Norovirus And Seasonal Influenza Tablet Vaccines At The 9th Vaccine & ISV Congress In Seoul 10/19/2015 10:51:10 AM
Vaxart, Inc. To Present Phase I Data At IDWeek 2015 Demonstrating Influenza Tablet Vaccine Induces Dose Dependent T Cell Responses 10/8/2015 9:54:22 AM
Vaxart, Inc. To Present Preclinical Data On Oral Quadrivalent Influenza Vaccine At ICAAC/ICC 2015 9/17/2015 10:46:04 AM
Vaxart, Inc. Announces Lancet ID Publication Of Influenza Tablet Vaccine Phase 1 Results 8/24/2015 9:52:04 AM